GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zafgen Inc (NAS:ZFGN) » Definitions » Price-to-Funds-From-Operations

Zafgen (Zafgen) Price-to-Funds-From-Operations : (As of May. 06, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Zafgen Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Zafgen (Zafgen) Business Description

Industry
Traded in Other Exchanges
N/A
Address
3 Center Plaza, Suite 610, Boston, MA, USA, 02108
Zafgen Inc is a US-based biopharmaceutical company. It focuses on developing novel therapeutics that treat the underlying biological mechanisms through the methionine aminopeptidase 2, or MetAP2, pathway. The lead product candidate of the company is ZGN-1061 which is a novel fumagillin-class MetAP2 inhibitor administered by subcutaneous injection. The company operates in the business of developing novel therapeutics. The company primarily carries its business operations in the United States.